In the absence of studies directly examining the role of CHD4 mutations in BC, indirect data from endometrial cancer suggest that the hot spot mutations R975H and R1162W disrupt protein function, promoting the loss of CHD4 in endometrial cancer cells, which induces a cancer stem cell phenotype to promote cancer progression. This evidence concerns the gene CHD4 and endometrial cancer.